Pulse oximetry screening for critical congenital heart disease

07/16/2014 | Journal of Pediatrics, The

Critical congenital heart disease (CCHD), which affects 1-3/1000 infants annually in the U.S., often is diagnosed by prenatal ultrasound or by clinical examination shortly after birth. Because a subset of these infants will be missed, there have been recent efforts to screen for CCHD with pulse oximetry screening (POS). This observational study shows that POS for CCHD can be successfully implemented for out-of-hospital births.

View Full Article in:

Journal of Pediatrics, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA